Verition Fund Management’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,004	Closed	-$11K	–	2717
2022 Q2	$11K	Buy	30,004 +4	+0%	+$1	﹤0.01%	2164
2022 Q1	$45K	Hold	30,000	–	–	﹤0.01%	1713
2021 Q4	$73K	Hold	30,000	–	–	﹤0.01%	1672
2021 Q3	$160K	Buy	+30,000	New	+$160K	﹤0.01%	1392